2022, Vol. 5, Issue 3, Part A
The clinical utilization of Neuroimaging methods in the management of glioblastoma: A review
Daniel D Otobo, Jacob O Adefila, Johnson Yonni, Anita A Omoruyi, Ugochukwu L Ezejiofor, Musa A Nuhu, Hayyatudeen O Tanko, Laughter Amamchukwu and Ishola A Mubarak
Glioblastomas (GBM) are the most commonly occurring primary brain tumor in adults. They account for the most years of life lost amongst all the intracranial neoplasia occurring in adulthood. GBMs are characterized by brain tissue invasions. Although a lot of research has been going on, not much has change in patient outcome. Researches in neuroimaging modalities have been at the forefront of the drive to better understand, assess and help in management of this neuro-oncological patients with glioblastomas. Some advances have been recorded over the years and also, some initially practiced modalities, withdrawn. This study aims to understand the breakthroughs that have been recorded and the barriers faced in GBM neuroimaging researches around the world and the clinical adoptions of this modalities.
Pages: 60-62 | Views: 351 | Downloads: 140
How to cite this article:
Daniel D Otobo, Jacob O Adefila, Johnson Yonni, Anita A Omoruyi, Ugochukwu L Ezejiofor, Musa A Nuhu, Hayyatudeen O Tanko, Laughter Amamchukwu, Ishola A Mubarak. The clinical utilization of Neuroimaging methods in the management of glioblastoma: A review. Int J Radiol Diagn Imaging 2022;5(3):60-62. DOI: 10.33545/26644436.2022.v5.i3a.277